Description
Neomycin is a polycationic aminoglycoside antibiotic that exhibits antibacterial and neuromodulatory activities; it was originally found in species of Streptomyces. Neomycin binds to 23S rRNA, constraining tRNA in the P-site, inhibiting translocation and ribosomal recycling; together, this results in inhibition of protein synthesis. Neomycin B binds and inhibits bacterial RNase P and bacterial T box antiterminator RNA. Neomycin B inhibits mammalian RNA splicing as well. Neomycin also noncompetitively inhibits cation channels, including P2X receptors and transient receptor potential vanilloid receptor 1 (TRPV1) channels. Additionally, this compound inhibits Ca2+ influx, preventing presynaptic release of acetylcholine and norepinephrine in feline superior cervical ganglia.
References
Wang L, Pulk A, Wasserman MR, et al. Allosteric control of the ribosome by small-molecule antibiotics. Nat Struct Mol Biol. 2012 Sep;19(9):957-63. PMID: 22902368.
Bongartz EV, Rettinger J, Hausmann R. Aminoglycoside block of P2X2 receptors heterologously expressed in Xenopus laevis oocytes. Purinergic Signal. 2010 Dec;6(4):393-403. PMID: 21437010.
Aukema KG, Chohan KK, Plourde GL, et al. Small molecule inhibitors of yeast pre-mRNA splicing. ACS Chem Biol. 2009 Sep 18;4(9):759-68. PMID: 19634919.
Anupam R, Denapoli L, Muchenditsi A, et al. Identification of neomycin B-binding site in T box antiterminator model RNA. Bioorg Med Chem. 2008 Apr 15;16(8):4466-70. PMID: 18329274.
Kawamoto SA, Sudhahar CG, Hatfield CL, et al. Studies on the mechanism of inhibition of bacterial ribonuclease P by aminoglycoside derivatives. Nucleic Acids Res. 2008 Feb;36(2):697-704. PMID: 18084035.
Raisinghani M, Premkumar LS. Block of native and cloned vanilloid receptor 1 (TRPV1) by aminoglycoside antibiotics. Pain. 2005 Jan;113(1-2):123-33. PMID: 15621372.
Wright JM, Collier B. The effects of neomycin upon transmitter release and action. J Pharmacol Exp Ther. 1977 Mar;200(3):576-87. PMID: 191590.
